Skip to content

FY2027 ICD-10-CM reference

H36.821: Proliferative sickle-cell retinopathy, right eye

By the HCC Buddy Coding Team

The official ICD-10-CM descriptor is Proliferative sickle-cell retinopathy, right eye. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Billable code. Verified against the official FY2027 order file.

CMS-HCC V28

  • HCC 108: Sickle Cell Disorders, Except Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero; Beta Thalassemia Major · RAF 0.146, Community Non-Dual Aged (CNA)
  • HCC 298: Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage · RAF 0.336, Community Non-Dual Aged (CNA)

Payment year 2027, 2026 dates of service. HCC from the CMS 2027 Initial ICD-10-CM Mappings; RAF from the CMS-HCC V28 relative factors. For 2027 dates of service, CMS has not yet published the payment year 2028 mappings.

CMS-HCC V24

Not used for payment year 2027 Medicare Advantage payment

ESRD

Source verification pending

PACE

Source verification pending

RxHCC

Source verification pending

HHS-HCC

Source verification pending

FY2027 Tabular instructions

Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.

Instructional note

Use an external cause code following the code for the eye condition, if applicable, to identify the cause of the eye condition

Source: H00-H59 (chapter, inherited).

Excludes2

certain conditions originating in the perinatal period (P04-P96)

Source: H00-H59 (chapter, inherited).

Excludes2

certain infectious and parasitic diseases (A00-B99)

Source: H00-H59 (chapter, inherited).

Excludes2

complications of pregnancy, childbirth and the puerperium (O00-O9A)

Source: H00-H59 (chapter, inherited).

Excludes2

congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)

Source: H00-H59 (chapter, inherited).

Excludes2

diabetes mellitus related eye conditions (E09.3-, E10.3-, E11.3-, E13.3-)

Source: H00-H59 (chapter, inherited).

Excludes2

endocrine, nutritional and metabolic diseases (E00-E88)

Source: H00-H59 (chapter, inherited).

Excludes2

injury (trauma) of eye and orbit (S05.-)

Source: H00-H59 (chapter, inherited).

Excludes2

injury, poisoning and certain other consequences of external causes (S00-T88)

Source: H00-H59 (chapter, inherited).

Excludes2

neoplasms (C00-D49)

Source: H00-H59 (chapter, inherited).

Excludes2

symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Source: H00-H59 (chapter, inherited).

Excludes2

syphilis related eye disorders (A50.01, A50.3-, A51.43, A52.71)

Source: H00-H59 (chapter, inherited).

Code first

underlying disease, such as:

Source: H36 (category, inherited).

Code first

lipid storage disorders (E75.-)

Source: H36 (category, inherited).

Code first

sickle-cell disorders (D57.-)

Source: H36 (category, inherited).

Excludes1

arteriosclerotic retinopathy (H35.0-)

Source: H36 (category, inherited).

Excludes1

diabetic retinopathy (E08.3-, E09.3-, E10.3-, E11.3-, E13.3-)

Source: H36 (category, inherited).

Source: CMS FY2027 Tabular List and Alphabetic Index.

Open Tabular instructions and code details

Compare the FY2027 additions, removals and billable-status changes

What does H36.821 mean in FY2027?

The official ICD-10-CM descriptor is Proliferative sickle-cell retinopathy, right eye. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Is H36.821 billable in FY2027?

The FY2027 order file marks H36.821 as billable. Check the complete Tabular instructions and documentation before assigning it.

Does H36.821 map to an HCC?

In the CMS 2027 Initial ICD-10-CM Mappings (payment year 2027, 2026 dates of service), H36.821 maps to CMS-HCC V28 HCC 108 (Sickle Cell Disorders, Except Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero; Beta Thalassemia Major) and HCC 298 (Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage). For 2027 dates of service, CMS has not yet published the payment year 2028 mappings. ESRD, RxHCC, PACE and HHS-HCC mappings are still pending verification for FY2027.

Source: CMS FY2027 ICD-10-CM order file. Read the FY2027 Official Guidelines.

Review the FY2026 April edition